WHO Launches Digital Health Action Plan To Guide Expert Group’s Work 25/10/2019 Grace Ren The World Health Organization has launched a plan to accelerate the use of digital technologies to meet global public health needs, following the first-ever meeting of a WHO Technical Advisory Group on digital health. “All governments are facing increasing demands to provide health services to their citizens, and many digital technologies offer solutions to help meet […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Breakthrough Ingestible Sensor Lets Patients Take Tuberculosis Drugs Independently 04/10/2019 Press release San Diego, US (4 October 2019) – A trial involving a safe, novel ingestible sensor connected to a paired mobile device that lets medical staff remotely monitor patients’ intake of tuberculosis (TB) medicine, has shown better results than directly observed therapy (DOT), where a healthcare worker watches the patient swallow medication, leading researchers to suggest […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Breakthrough Ingestible Sensor Lets Patients Take Tuberculosis Drugs Independently 04/10/2019 Press release San Diego, US (4 October 2019) – A trial involving a safe, novel ingestible sensor connected to a paired mobile device that lets medical staff remotely monitor patients’ intake of tuberculosis (TB) medicine, has shown better results than directly observed therapy (DOT), where a healthcare worker watches the patient swallow medication, leading researchers to suggest […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Breakthrough Ingestible Sensor Lets Patients Take Tuberculosis Drugs Independently 04/10/2019 Press release San Diego, US (4 October 2019) – A trial involving a safe, novel ingestible sensor connected to a paired mobile device that lets medical staff remotely monitor patients’ intake of tuberculosis (TB) medicine, has shown better results than directly observed therapy (DOT), where a healthcare worker watches the patient swallow medication, leading researchers to suggest […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
Breakthrough Ingestible Sensor Lets Patients Take Tuberculosis Drugs Independently 04/10/2019 Press release San Diego, US (4 October 2019) – A trial involving a safe, novel ingestible sensor connected to a paired mobile device that lets medical staff remotely monitor patients’ intake of tuberculosis (TB) medicine, has shown better results than directly observed therapy (DOT), where a healthcare worker watches the patient swallow medication, leading researchers to suggest […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
AI & Healthcare Conference Considers Access, Equity & Gender 11/09/2019 Elaine Ruth Fletcher Digital health holds the potential to transform health systems so that they become more proactive and responsive to patients, advocates said at Wednesday’s launch of a two-day international conference that brought together members of the global healthcare and artificial intelligence (AI) communities in Switzerland’s pharmaceutical industry hub, Basel. But using AI doesn’t inherently empower women […] Continue reading -> FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access 19/08/2019 Grace Ren The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, the world’s leading cause of death by infectious disease. Pretomanid is only the third TB drug to be approved in over […] Continue reading -> FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis 15/08/2019 Press release [TB Alliance] NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) […] Continue reading -> Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts
Global Innovation Index 2019 Released, Focus On The Future of Medical Innovation 24/07/2019 David Branigan The Global Innovation Index 2019 was released today with an overarching theme of “Creating Healthy Lives – The Future of Medical Innovation.” In addition to ranking countries according to their innovation performance on 80 indicators, this year’s Index also analyses the medical innovation landscape, and how emerging innovations, such as artificial intelligence (AI), genomics, and […] Continue reading -> Posts navigation Newer posts